FDA Approves ACTEMRAA for Children Living with a Rare Form of Arthritis

The medicine can be used in children two years of age and older with active disease.

http://eon.businesswire.com/news/eon/20130430006327/en/FDA-Approves-ACTEMRA%C2%AE-Children-Living-Rare-Form